Gentian Diagnostics
Be the first to follow this company
Gentian Diagnostics is a Norwegian company that develops various products in healthcare. Examples are diagnostic tests with the goal of developing and streamlining diagnostic treatment, which includes treatment of cancer and cardiovascular disease. A large part of the business includes R&D development. The company was founded in 1998 and is headquartered in Moss.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
GENT
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
General meeting
29.04.2024
Interim report
30.04.2024
Interim report
29.08.2024
Interim report
31.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Vatne Equity AS | 13.7 % | 13.7 % |
Kvantia AS | 10.5 % | 10.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Gentian Diagnostics: Notice of annual general meeting
Gentian Diagnostics: CEO resignation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools